Legend Biotech (LEGN) Total Debt: 2020-2025
Historic Total Debt for Legend Biotech (LEGN) over the last 5 years, with Sep 2025 value amounting to $171.9 million.
- Legend Biotech's Total Debt fell 42.04% to $171.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.9 million, marking a year-over-year decrease of 42.04%. This contributed to the annual value of $301.2 million for FY2024, which is 7.06% up from last year.
- According to the latest figures from Q3 2025, Legend Biotech's Total Debt is $171.9 million, which was down 44.59% from $310.3 million recorded in Q2 2025.
- Legend Biotech's 5-year Total Debt high stood at $310.3 million for Q2 2025, and its period low was $2.5 million during Q2 2022.
- Its 3-year average for Total Debt is $278.2 million, with a median of $286.4 million in 2024.
- Per our database at Business Quant, Legend Biotech's Total Debt slumped by 91.99% in 2022 and then soared by 10,708.27% in 2023.
- Quarterly analysis of 5 years shows Legend Biotech's Total Debt stood at $120.5 million in 2021, then soared by 118.69% to $263.4 million in 2022, then climbed by 6.79% to $281.3 million in 2023, then rose by 7.06% to $301.2 million in 2024, then tumbled by 42.04% to $171.9 million in 2025.
- Its Total Debt stands at $171.9 million for Q3 2025, versus $310.3 million for Q2 2025 and $305.7 million for Q1 2025.